Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
Category
News
Biden To Reverse Trump X Waiver Policy
News
January 25, 2021
Federal Gov’t Expands Access to Buprenorphine for OUD
News
January 14, 2021
DEA Expanding Surveillance of Prescription Drug Data
News
November 11, 2020
DEA Supercharges Patient, Prescriber, Pharmacist Surveillance
News
November 9, 2020
Stigma Against OUD Medications Persists
Report
October 20, 2020
Prepare to E-Prescribe Controlled Drugs for Medicare Participants
News
July 28, 2020
FDA Recommends Discussing Naloxone When Prescribing Opioids
News
July 23, 2020
Drug Overdose Deaths Up 4.6% in 2019
News
July 16, 2020
DOJ Targets Pain Management Specialists
News
July 4, 2020
Pandemic Unleashes a Spike in Overdoses, Deaths
News
June 29, 2020
COVID-19: OUD Practice and Policy Considerations
News
April 3, 2020
Research Ties Suicide Risk to Opioid Cessation
News
March 3, 2020
More
« Previous